Pain (9 to 24 hours) · people undergoing laparoscopic cholecystectomy.
1 finding from 1 review
All‐cause mortality · people undergoing laparoscopic cholecystectomy.
1 finding from 1 review
Opioids versus NSAIDs · people undergoing laparoscopic cholecystectomy.
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Live birth rate · tubal disease in women due to undergo in vitro fertilisation
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Overall rate of surgical complications · tubal disease in women due to undergo in vitro fertilisation
1 finding from 1 review
Clinical pregnancy rate · tubal disease in women due to undergo in vitro fertilisation
It is very uncertain whether transvaginal aspiration of hydrosalpingeal fluid changes clinical pregnancy rate compared with laparoscopic salpingectomy (very low certainty).
1 finding from 1 review
Miscarriage · tubal disease in women due to undergo in vitro fertilisation
It is very uncertain whether transvaginal aspiration of hydrosalpingeal fluid changes miscarriage rate compared with laparoscopic salpingectomy (very low certainty).
1 finding from 1 review
Ectopic pregnancy · tubal disease in women due to undergo in vitro fertilisation
It is very uncertain whether transvaginal aspiration of hydrosalpingeal fluid changes ectopic pregnancy rate compared with laparoscopic salpingectomy (very low certainty).
1 finding from 1 review
Urinary continence within 1 week after catheter removal MCID: 5% absolute difference · men (ages > 18 years) with clinically localized prostate cancer
Posterior reconstruction showed no clear difference in urinary continence within 1 week after catheter removal MCID: 5%… compared with no posterior reconstruction (low certainty).
1 finding from 1 review
Urinary continence 3 months after surgery MCID: 5% absolute difference · men (ages > 18 years) with clinically localized prostate cancer
Posterior reconstruction showed no clear difference in urinary continence 3 months after surgery MCID: 5% absolute difference compared with no posterior reconstruction (low certainty).
1 finding from 1 review
Serious adverse events · men (ages > 18 years) with clinically localized prostate cancer
Posterior reconstruction showed no clear difference in serious adverse events compared with no posterior reconstruction (moderate certainty).
1 finding from 1 review
Urinary continence 6 months after surgery MCID: 5% absolute difference · men (ages > 18 years) with clinically localized prostate cancer
Posterior reconstruction showed no clear difference in urinary continence 6 months after surgery MCID: 5% absolute difference compared with no posterior reconstruction (moderate certainty).
1 finding from 1 review
Urinary continence 12 months after surgery MCID: 5% absolute difference · men (ages > 18 years) with clinically localized prostate cancer
Posterior reconstruction showed no clear difference in urinary continence 12 months after surgery MCID: 5% absolute… compared with no posterior reconstruction (low certainty).
1 finding from 1 review
Potency 12 months after surgery MCID: 5% absolute difference · men (ages > 18 years) with clinically localized prostate cancer
It is very uncertain whether posterior reconstruction changes potency recovery 12 months after surgery MCID: 5% absolute difference compared with no posterior reconstruction (very low certainty).
1 finding from 1 review
Positive surgical margins MCID: 5% absolute difference · men (ages > 18 years) with clinically localized prostate cancer
Posterior reconstruction showed no clear difference in positive surgical margins MCID: 5% absolute difference compared with no posterior reconstruction (low certainty).
1 finding from 1 review
Urinary continence within 1 week after catheter removal MCID: 5% absolute difference · men (ages > 18 years) with clinically localized prostate cancer
Retzius‐sparing RALP probably leads to higher urinary continence within 1 week after catheter removal MCID: 5%… compared with standard RALP (moderate certainty).
1 finding from 1 review
Urinary continence 3 months after surgery MCID: 5% absolute difference · men (ages > 18 years) with clinically localized prostate cancer
Retzius‐sparing RALP may leads to higher urinary continence 3 months after surgery MCID: 5% absolute difference compared with standard RALP (low certainty).
1 finding from 1 review
Serious adverse events · men (ages > 18 years) with clinically localized prostate cancer
It is very uncertain whether retzius‐sparing RALP changes serious adverse events compared with standard RALP (very low certainty).
1 finding from 1 review
Urinary continence 12 months after surgery MCID: 5% absolute difference · men (ages > 18 years) with clinically localized prostate cancer
Retzius‐sparing RALP showed no clear difference in urinary continence 12 months after surgery MCID: 5% absolute… compared with standard RALP (moderate certainty).
1 finding from 1 review
Potency 12 months after surgery MCID: 5% absolute difference · men (ages > 18 years) with clinically localized prostate cancer
It is very uncertain whether retzius‐sparing RALP changes potency 12 months after surgery MCID: 5% absolute difference compared with standard RALP (very low certainty).
1 finding from 1 review